US78349D1072 - Common Stock
RXSIGHT INC
NASDAQ:RXST (10/15/2024, 5:51:31 PM)
After market: 48.52 -1.09 (-2.2%)49.61
-0.65 (-1.29%)
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 374 full-time employees. The company went IPO on 2021-07-30. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. The company designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
RXSIGHT INC
100 Columbia Street, Suite 120
Aliso Viejo CALIFORNIA
P: 19495217822
CEO: Ron Kurtz
Employees: 374
Website: https://www.rxsight.com/
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing...
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91.
Here you can normally see the latest stock twits on RXST, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: